Efficacy of Glucagon-Like Peptide-1 Analogs in Nonalcoholic Fatty Liver Disease: A Systematic Review
Getnet Teshome,1 Sintayehu Ambachew,2 Alebachew Fasil,2 Molla Abebe2 1University of Gondar Comprehensive Specialized Hospital, University of Gondar, Gondar, Amhara, Ethiopia; 2Department of Clinical Chemistry, University of Gondar, Gondar, Amhara, EthiopiaCorrespondence: Getnet TeshomeUniversity of...
Main Authors: | Teshome G, Ambachew S, Fasil A, Abebe M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-09-01
|
Series: | Hepatic Medicine : Evidence and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/efficacy-of-glucagon-like-peptide-1-analogs-in-nonalcoholic-fatty-live-peer-reviewed-article-HMER |
Similar Items
-
The Role of Glucagon-like Peptides in Experimental Type 1 Diabetes
by: Hadjiyianni, Irene Ioanna
Published: (2010) -
The Role of Glucagon-like Peptides in Experimental Type 1 Diabetes
by: Hadjiyianni, Irene Ioanna
Published: (2010) -
One Year’s Treatment with the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide Decreases Hepatic Fat Content in Women with Nonalcoholic Fatty Liver Disease and Prior Gestational Diabetes Mellitus in a Randomized, Placebo-Controlled Trial
by: Louise Vedtofte, et al.
Published: (2020-10-01) -
American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD)
by: Barb, D., et al.
Published: (2022) -
Radiation-induced oxidative injury of the ileum and colon is alleviated by glucagon-like peptide-1 and -2
by: Mustafa Deniz, et al.
Published: (2015-04-01)